title: Carfilzomib: a rare cause of posterior reversible encephalopathy syndrome.
authors.affiliation: Department of Internal Medicine, The University of Texas Houston, Health Science Center, Houston, TX, USA. Nurit.S.Katz@uth.tmc.edu.
authors.forename: Nurit
authors.initials: N
authors.lastname: Katz-Agranov
authors.affiliation: Department of Neurology, The University of Texas, Health Science Center, Houston, TX, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Padilla
authors.affiliation: Department of Internal Medicine, The University of Texas Houston, Health Science Center, Houston, TX, USA.
authors.forename: Joanna
authors.initials: J
authors.lastname: Scoon
authors.affiliation: Department of Pulmonary Critical Care and Sleep Medicine, The University of Texas, Health Science Center, Houston, TX, USA.
authors.forename: Sujith V
authors.initials: SV
authors.lastname: Cherian
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003907:Dexamethasone / Q000008:administration & dosage; D057915:Drug Substitution; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D009842:Oligopeptides / Q000008:administration & dosage / Q000009:adverse effects*; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000000981:diagnostic imaging; D061988:Proteasome Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012640:Seizures / Q000139:chemically induced
chemical_list: D009842:Oligopeptides; D061988:Proteasome Inhibitors; C524865:carfilzomib; D003907:Dexamethasone